Similar to the HCRU, the overall annual HCRU direct cost also showed a trend toward highest mean AD-related HCRU gross cost (per patient) among moderate-to-severe treated AD cohort (531.5 USD) followed by the mild-to-moderate treated AD cohort (378.4 USD) and lowest for the untreated AD cohort (144.0 USD).
← all excerpts
Healthcare Resource Utilization and Direct Cost of Patients with Atopic Dermatitis in Dubai, United Arab Emirates: A Retrospective Cohort Study.
1
—
—